News | April 08, 2025
Lyka Labs secures Indian patent for Pregabalin Gel 8%
Pregabalin Gel 8% is a novel topical solution for diabetic neuropathic pain
Pregabalin Gel 8% is a novel topical solution for diabetic neuropathic pain
Lyka has received the CDSCO approval for manufacturing and marketing of Pregabalin Gel 8% w/w
The Pregabalin capsules has a market size of ~US$248 mn per IQVIA
Pregabalin Capsules have an estimated market size of US $244 million for twelve months ending Sep 2022 according to IQVIA
Silodosin capsules treat signs and symptoms of an enlarged prostate gland
While Pregabalin will be manufactured at the Aurangabad facility, Iloperidone will be manufactured at the Goa facility
Breakthrough Therapy designation for pain associated with DPN granted by FDA
Asahi Songwon Colors' shareholding in ALSPL has increased from 78% to 100%
36.4% of patients with diabetic neuropathic pain in 2021 were completely treatment refractory and would benefit from new treatment options.
The group now has 322 approvals and has so far filed over 428 ANDAs since the commencement of the filing process in FY 2003-04
Subscribe To Our Newsletter & Stay Updated
